DIFFERENTIAL LEUKOCYTE COUNT IN BABIES TREATED WITH NATURAL SURFACTANT

被引:1
作者
AMATO, M
HUPPI, P
MARKUS, D
SCHNEIDER, H
机构
[1] Division of Neonatology, Department of Pediatrics, Children's Hospital, Division of Neonatology, Department of Obstetrics and Gynecology, University of Berne, Berne
关键词
D O I
10.1055/s-2007-994531
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The potential of exogenous replacement therapy in su surfactant-deficient states such as neonatal respiratory distress syndrome (RDS) is an area of intense clinical interest today. At present, a fundamental problem with any type of exogenous surfactant is the uncertainty about potential effects on physiological defense mechanisms, such as differentiation and mobilization of peripheral leukocytes. Considering that newborn infants with proven bacterial infections have abnormal values of segmented (neutrophil) and nonsegmented (band) polymorphonuclear leukocytes, we studied 42 placebo- versus Curosurf-treated babies with severe RDS. Differential white blood cell (WBC) count was serially performed before and after treatment during the first days of lifer The statistically significant increase in the proportion of bands in surfactant-treated babies did not coincide with clinical and bacteriologic evidence of possible infection. Some molecular interaction mechanisms influencing immature to mature WBC ratio are supposed. Among a variety of influences on the leukocyte count, surfactant replacement therapy needs to be considered for proper interpretation of hematologic data in babies treated for RDS.
引用
收藏
页码:33 / 36
页数:4
相关论文
共 35 条
[1]  
Gl A., Hui Y.T., Milner R., Zipuiski A., Neutrophil and band counts in the diagnosis of neonatal infections, Pediatrics, 54, pp. 38-48, (1974)
[2]  
Christensen D., Bradley P., Rothstein G., The leukocyte left shift in clinical and experimental neonatal sepsis, J Pedi-atr, 98, pp. 101-105, (1981)
[3]  
Davies N.P., Huggins A.G., Snijders R.J., Blood leukocyte count in the human fetus, Arch Dis Child, 67, pp. 399-403, (1992)
[4]  
Morens D.M., WBC count and differential, Am J. Dis Child, 133, pp. 25-27, (1979)
[5]  
Amato M., Ruckstuhl C.H., Von Murait G., C-réactivés Protein im Serum Frühgeborener, Schweiz Med Wochenschr, 114, pp. 112-414, (1984)
[6]  
Mathers N.J., Pohlandt F., Diagnostic audit of C-reactive protein in neonatal infection, Eur J Pediatr, 146, pp. 147-151, (1987)
[7]  
Rodwe H.K.L., Leslie A.L., Tudehope D.A., Early diagnosis of neonatal sepsis using a hematological scoring system, J Pediatr, 112, pp. 761-767, (1988)
[8]  
Manroe B.L., Weinberg A.G., Rosenfeld C.R., The neonatal blood count in health and disease, Reference values for neutrophilic cells. J Pediatr, 95, pp. 89-98, (1979)
[9]  
Zipurski A., Palko J., Milner K., The hematology of bacterial infections in premature infants, Pediatrics, 57, pp. 839-853, (1976)
[10]  
Otero L., Colon C., Reynolds P., Neonatal leukocytosis associated with prenatal administration of dexamethasone, Pediatrics, 68, pp. 778-780, (1981)